An elevated level of the protein CA-125 in blood is considered an indicator of whether an ovarian tumor is benign or malignant. This measure, however, can often be inaccurate. Another option is an ultrasound examination of the tumor. An experienced ultrasound examiner can often accurately classify an ovarian tumor using a method of pattern recognition.
Dirk Timmerman, M.D., Ph.D., of Katholieke Universiteit Leuven in Belgium and colleagues conducted a prospective study of 1,066 women to compare the ability of these two methods to discriminate between benign and malignant ovarian tumors. All of the women had an ultrasound examination within 120 days of their surgery to remove the tumor. Of these women, 809 had given blood samples before their surgery, and these samples were later analyzed for CA-125.
They found that experienced ultrasound examiners correctly classified 93 percent of the tumors as benign or malignant, while CA-125 levels correctly classified 83 percent of tumors at best.
“We hope our results will encourage responsible parties to expend more effort and more resources to educate and train those who perform gynecologic ultrasound examinations, so that the potential of the ultrasound technique can be maximized,” the authors write.
Source: Journal of the National Cancer Institute
Related stories:
Treatment advances for fibroids, menopause
Women with fibroids and endometriosis facing the possibility of hysterectomy may now choose less invasive treatment options to preserve fertility, according to Yale professor Aydin Arici, M.D., who will direct a scientific session exploring these alternatives at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting May 3-7 in New Orleans, Louisiana.
Freezing bone cancer tumors reduces pain, study shows
Cryoablation, a procedure most commonly associated with destroying kidney and prostate tumors by freezing them, has been shown to offer durable pain relief of cancer that has spread to bone. The procedure freezes and shrinks or destroys cancerous tumors in or near bone.
Researchers explore nanotechnology as diagnostic and treatment tool
Nanotechnology is revolutionizing the way things are constructed -- from stain resistant clothing to stronger, yet lighter tennis rackets. However, the biggest impact of nanotechnology in the future is expected to be in the healthcare industry.
Gene that causes childhood cancer neuroblastoma is found
Scientists have discovered gene mutations that are the main cause of the inherited version of the childhood cancer neuroblastoma. In addition, the researchers found that the same mutations play a significant role in high-risk forms of non-inherited neuroblastoma, the more common form of the disease.
Scientists nail childhood nerve cancer gene
Researchers have identified the hereditary gene mutations behind a deadly form of childhood cancer, opening the way to genetic tests in high-risk families, according to study released Sunday.
Symptom screening plus a simple blood test improves early detection of ovarian cancer
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer – abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating – when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online in
CANCER.
Majority of kidney cancers diagnosed at earliest stage
Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center researcher.
Nano-sized technology has super-sized effect on tumors
Anyone facing chemotherapy would welcome an advance promising to dramatically reduce their dose of these often harsh drugs. Using nanotechnology, researchers at Washington University School of Medicine in St. Louis have taken a step closer to that goal.